Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127

Biochim Biophys Acta. 2015 Jul;1853(7):1693-701. doi: 10.1016/j.bbamcr.2015.04.004. Epub 2015 Apr 15.

Abstract

In eukaryotic protein synthesis the translation initiation factor 3 (eIF3) is a key player in the recruitment and assembly of the translation initiation machinery. Mammalian eIF3 consists of 13 subunits, including the loosely associated eIF3j subunit that plays a stabilizing role in the eIF3 complex formation and interaction with the 40S ribosomal subunit. By means of both co-immunoprecipitation and mass spectrometry analyses we demonstrate that the protein kinase CK2 interacts with and phosphorylates eIF3j at Ser127. Inhibition of CK2 activity by CX-4945 or down-regulation of the expression of CK2 catalytic subunit by siRNA cause the dissociation of j-subunit from the eIF3 complex as judged from glycerol gradient sedimentation. This finding proves that CK2-phosphorylation of eIF3j is a prerequisite for its association with the eIF3 complex. Expression of Ser127Ala-eIF3j mutant impairs both the interaction of mutated j-subunit with the other eIF3 subunits and the overall protein synthesis. Taken together our data demonstrate that CK2-phosphorylation of eIF3j at Ser127 promotes the assembly of the eIF3 complex, a crucial step in the activation of the translation initiation machinery.

Keywords: Protein kinase CK2; Translation initiation activation; eIF3 assembly; eIF3 complex; eIF3j phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Casein Kinase II / antagonists & inhibitors
  • Casein Kinase II / metabolism*
  • Eukaryotic Initiation Factor-3 / metabolism*
  • Gene Silencing / drug effects
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Mutation / genetics
  • Naphthyridines / pharmacology
  • Phenazines
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism*
  • Protein Binding / drug effects
  • Protein Biosynthesis* / drug effects
  • Protein Subunits / metabolism
  • Substrate Specificity / drug effects

Substances

  • Eukaryotic Initiation Factor-3
  • Naphthyridines
  • Phenazines
  • Protein Subunits
  • Phosphoserine
  • silmitasertib
  • Casein Kinase II